For almost 75 years the International Union Against Cancer (UICC) has been the only international non-governmental organisation dedicated exclusively to the global control of cancer. But with many societies currently going global’, including ASCO and [more]
A committed medical oncologist, David Khayat reluctantly dragged himself away from his patients in 2003 to oversee the implementation of the French cancer plan. This grand and sweeping venture exercises huge control over cancer services, [more]
Doctors use trial-based evidence and years of experience to assess risks of treatment and relapse. But patients make choices based on their own experiences and priorities. How can doctors best explore treatment options with patients? [more]
The use of nucleic acid therapies to block RNA function was first described in 1978. The latest generation of these compounds, LNA antagonists, is now overcoming the main obstacle to the success of its predecessors, [more]
The biology of a cancer is a key factor determining prognosis and prediction of response. So should we still be characterising it by the size of the tumour and spread of the disease? In a [more]
There are smokers in Russia alive today thanks to David Zaridze and the lead he took in halving tar levels 20 years ago. He has a long history in cancer prevention, but believes the biggest [more]
Use of at least two standard aspirin weekly, for 10 years or more, reduces colon cancer risk in women. Subject to certain caveats, aspirin should be considered for colon cancer prophylaxis. Download full article
A recent analysis of prognostic factors may help identify which follicular and mantle cell lymphoma patients should be excluded from trials of single-agent rituximab therapy. Download full article
Selected press reports compiled by the ESO Cancer Media Centre Download full article